Literature DB >> 33881731

The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas.

Taishi Amano1, Tomohiko Masumoto2, Hiroyoshi Akutsu3, Noriaki Sakamoto4, Sodai Hoshiai5, Kensaku Mori5, Takahito Nakajima5.   

Abstract

PURPOSE: To investigate the relationship between dynamic magnetic resonance imaging (MRI) findings and hormonal activity in pituitary adenomas.
METHODS: We retrospectively evaluated the dynamic MRI findings in 244 patients with pathologically confirmed pituitary adenomas and a diagnosis of clinically active prolactin (PRL)-producing adenomas. Among the 244 pituitary adenomas, 55, 16, 6, and 4 produced growth hormone (GH), PRL, adrenocorticotropic hormone, and thyroid-stimulating hormone, respectively, while 163 were non-functioning (NF) adenomas. For each adenoma, we calculated the washout rate (WR) and early (EER) and delayed (DER) tumour-to-normal-tissue enhancement ratios.
RESULTS: The respective mean values of the WR, EER, and DER were 9.4%, 75.2%, and 64.5% for GH-producing adenomas; 6.2%, 117.1%, and 106.2% for PRL-producing adenomas; and 5.4%, 116.7%, and 108.7% for NF adenomas. GH-producing adenomas had significantly lower EER and DER values than PRL-producing (P < 0.001) and NF adenomas (P < 0.001). In ROC analysis of GH-producing and non-GH-producing adenomas, the areas under the curves of WR, EER, and DER were 0.593, 0.825, and 0.857, respectively.
CONCLUSION: There are differences in dynamic MRI features between GH-producing and non-GH-producing adenomas, which suggests that EER and DER may be useful for diagnosing GH-producing adenomas.

Entities:  

Keywords:  Dynamic contrast enhancement; Magnetic resonance imaging; Pituitary adenoma; Pituitary hormonal activity

Year:  2021        PMID: 33881731     DOI: 10.1007/s11604-021-01121-9

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  13 in total

1.  MRI of pituitary adenomas in acromegaly.

Authors:  B Marro; A Zouaoui; M Sahel; N Crozat; S Gerber; N Sourour; K Sag; C Marsault
Journal:  Neuroradiology       Date:  1997-06       Impact factor: 2.804

2.  Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation.

Authors:  Akira Hagiwara; Yuichi Inoue; Kenichi Wakasa; Tomoko Haba; Takahiko Tashiro; Takeshi Miyamoto
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

3.  Predictive role of dynamic contrast enhanced T1-weighted MR sequences in pre-surgical evaluation of macroadenomas consistency.

Authors:  Andrea Romano; Valeria Coppola; Mariangela Lombardi; Luigi Lavorato; Domenica Di Stefano; Emanuela Caroli; Maria Camilla Rossi Espagnet; Francesca Tavanti; Giuseppe Minniti; Giuseppe Trillò; Alessandro Bozzao
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

4.  Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.

Authors:  Y Miki; M Matsuo; S Nishizawa; Y Kuroda; A Keyaki; Y Makita; J Kawamura
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

5.  Microvessel density in pituitary adenomas and carcinomas.

Authors:  S Vidal; K Kovacs; E Horvath; B W Scheithauer; T Kuroki; R V Lloyd
Journal:  Virchows Arch       Date:  2001-06       Impact factor: 4.064

6.  Role of High-Resolution Dynamic Contrast-Enhanced MRI with Golden-Angle Radial Sparse Parallel Reconstruction to Identify the Normal Pituitary Gland in Patients with Macroadenomas.

Authors:  R Sen; C Sen; J Pack; K T Block; J G Golfinos; V Prabhu; F Boada; O Gonen; D Kondziolka; G Fatterpekar
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

7.  MRI of pituitary macroadenomas with reference to hormonal activity.

Authors:  P Lundin; R Nyman; P Burman; P O Lundberg; C Muhr
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 8.  Magnetic resonance imaging of pituitary adenomas.

Authors:  Jean-François Bonneville; Fabrice Bonneville; Françoise Cattin
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

9.  Clinical implications of dynamic MRI for pituitary adenomas: clinical and histologic analysis.

Authors:  Y Kanou; K Arita; K Kurisu; A Tomohide; K Iida
Journal:  J Clin Neurosci       Date:  2002-11       Impact factor: 1.961

10.  Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma.

Authors:  W T Yuh; D J Fisher; H D Nguyen; E T Tali; F Gao; T M Simonson; J A Schlechte
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

View more
  2 in total

1.  Assessment of the sequential time-signal enhancement curve of dynamic contrast-enhanced MRI might be effective in diagnosing growth hormone-producing pituitary adenomas.

Authors:  Taishi Amano; Tomohiko Masumoto; Hiroyoshi Akutsu; Noriaki Sakamoto; Sodai Hoshiai; Kensaku Mori; Takahito Nakajima
Journal:  Jpn J Radiol       Date:  2021-07-12       Impact factor: 2.374

2.  Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.

Authors:  Chen-Xi Liu; Sheng-Zhong Wang; Li-Jun Heng; Yu Han; Yu-Hui Ma; Lin-Feng Yan; Ying Yu; Wen Wang; Yu-Chuan Hu; Guang-Bin Cui
Journal:  J Comput Assist Tomogr       Date:  2022 Jan-Feb 01       Impact factor: 1.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.